Recombinant Xenopus tropicalis Protein FAM136A (fam136a)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Xenopus tropicalis Protein FAM136A (fam136a)

Recombinant Xenopus tropicalis Protein FAM136A (fam136a) is a mitochondrial protein expressed in the Western clawed frog (Silurana tropicalis). It is produced via recombinant DNA technology, enabling controlled studies of its structure, function, and role in biological processes. FAM136A is conserved across species and has been implicated in human diseases such as familial Meniere’s disease, making it a critical target for biomedical research .

Expression Systems

  • Host: Yeast (Saccharomyces cerevisiae) or HEK293 cells .

  • Expression Region: AA 1–138 (full-length protein) .

  • Purity:

    • 80% (HEK293-expressed)

    • 85% (yeast-expressed) .

Functional Studies

  • Antibody Production: Used as an immunogen to generate antibodies targeting FAM136A .

  • Disease Modeling:

    • Linked to familial Meniere’s disease due to mutations disrupting mitochondrial function in inner ear tissues .

    • Expressed in neurosensorial epithelium of the crista ampullaris (rat model) .

  • Protein-Protein Interaction Screens: Tags enable pull-down assays to identify binding partners .

Experimental Advantages

  • Species-Specificity: Enables comparative studies in Xenopus tropicalis, a diploid model with high genomic synteny to humans .

  • CRISPR Compatibility: Facilitates functional knockout studies in F0-generation embryos .

Role in Disease

Study FocusKey FindingsSource
Familial Meniere’s Disease- Nonsense mutations in FAM136A produce truncated proteins linked to hearing loss and vestibular dysfunction .
Mitochondrial Function- Localized to mitochondria; loss disrupts energy metabolism in sensory hair cells .

Xenopus tropicalis as a Model

  • Genetic Tools: High fecundity, rapid development, and CRISPR efficiency enable large-scale functional screens .

  • Evolutionary Conservation: Shares 79% of human disease-associated genes, validating translational relevance .

Future Research Directions

  • Mechanistic Studies: Elucidate FAM136A’s role in mitochondrial dynamics and ion transport.

  • Therapeutic Screening: Use recombinant FAM136A to identify compounds rescuing Meniere’s disease phenotypes .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format unless you specify a format requirement when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. Proteins are shipped with blue ice packs by default; dry ice shipping is available upon request for an additional fee.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
fam136aProtein FAM136A
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-138
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)
Target Names
fam136a
Target Protein Sequence
MAEEQQNRLQ NAIDTMVKSL ERDNIRKMQG KMFRCSAQCC EDNGASMQQV HHCIERCHTP LAQAQSLVTN ELERFQNRLA RCTMHCNDKA KDSFDSGSKE AQVKAQLEGC VIKCAEEHMN LIPSMTKKLK DALAQADK
Uniprot No.

Q&A

What is FAM136A and what is known about its function in Xenopus tropicalis?

FAM136A (Family with Sequence Similarity 136, Member A) is a protein with relatively limited characterization in Xenopus tropicalis. Based on comparative studies with other species, FAM136A appears to encode a mitochondrial protein, though its specific function remains largely unknown . Immunohistochemical studies in rat inner ear tissue have demonstrated that FAM136A co-localizes with the mitochondrial marker COX IV in the basal part of hair cells in the crista ampullaris, suggesting potential roles in sensory epithelium function . The protein's conservation across vertebrates, including frogs, suggests it likely serves important cellular functions.

How conserved is FAM136A across different amphibian species?

FAM136A shows significant conservation across amphibian species, particularly between Xenopus laevis and Xenopus tropicalis. The protein sequence exhibits high similarity between these closely related species, which supports the use of either model for studying FAM136A function . Both species express FAM136A and have been utilized in various genetic and biochemical studies exploring protein function in amphibians . When comparing amphibian FAM136A to mammalian orthologs, key functional domains appear to be preserved, suggesting evolutionary conservation of critical functional regions.

What are the known structural characteristics of Xenopus tropicalis FAM136A?

The structural characteristics of Xenopus tropicalis FAM136A remain partially characterized. Based on available data, FAM136A is expressed as multiple transcript isoforms that encode protein variants . The full-length protein appears to contain functional domains important for mitochondrial localization and function. Recombinant expression systems have successfully produced the protein with various tags (including His tags) that maintain structural integrity for experimental applications . Multiple isoforms have been detected through both mRNA analysis and immunoblotting, suggesting differential processing or alternative splicing may generate functional diversity in this protein family .

What expression systems are most effective for recombinant Xenopus tropicalis FAM136A production?

Yeast expression systems have proven particularly effective for recombinant production of Xenopus FAM136A proteins. The yeast expression system provides an economical and efficient eukaryotic platform for both secretion and intracellular expression of recombinant proteins . For Xenopus tropicalis FAM136A specifically, yeast expression systems consistently yield protein with greater than 90% purity suitable for applications such as ELISA . Mammalian cell expression systems (such as HEK-293 cells) offer an alternative approach that may produce protein with post-translational modifications more closely resembling the native state, though at higher cost and potentially lower yield than yeast-based systems .

What purification strategies yield the highest purity of recombinant Xenopus tropicalis FAM136A?

The most effective purification approach for recombinant Xenopus tropicalis FAM136A involves affinity chromatography utilizing His-tag fusion proteins. This method typically yields protein preparations with purity exceeding 90% as determined by SDS-PAGE analysis . The purification workflow generally involves:

  • Expression of His-tagged FAM136A in yeast expression systems

  • Cell lysis under conditions that maintain protein solubility

  • Immobilized metal affinity chromatography (IMAC) using Ni-NTA or similar matrices

  • Washing steps with increasing imidazole concentrations to remove non-specifically bound proteins

  • Elution of purified FAM136A with high imidazole buffer

  • Optional size exclusion chromatography for applications requiring exceptionally high purity

This approach consistently yields recombinant FAM136A suitable for applications including ELISA and other functional studies .

How can I verify proper folding and activity of recombinant Xenopus tropicalis FAM136A?

Verification of proper folding and activity for recombinant Xenopus tropicalis FAM136A requires multiple analytical approaches:

  • Structural integrity analysis:

    • Circular dichroism spectroscopy to assess secondary structure content

    • Size exclusion chromatography to confirm monomeric state vs. aggregation

    • Limited proteolysis to verify compact folding

  • Functional assays:

    • Immunoreactivity with conformation-specific antibodies

    • Co-localization studies with mitochondrial markers (such as COX IV) in cellular systems

    • Binding studies with potential interaction partners identified through comparative studies

  • Activity verification:

    • While specific enzymatic activities remain undefined for FAM136A, mitochondrial import assays can verify proper targeting

    • Complementation assays in FAM136A-deficient systems can assess functional activity

Multiple transcript isoforms should be evaluated individually, as functional differences between isoforms have been observed in expression studies .

How can CRISPR/Cas9 be used to study FAM136A function in Xenopus tropicalis?

CRISPR/Cas9 gene editing represents a powerful approach for studying FAM136A function in Xenopus tropicalis. This methodology offers several key advantages for FAM136A functional studies:

  • Efficient gene knockout generation:

    • Xenopus tropicalis embryos readily accept microinjection of CRISPR/Cas9 components

    • Simple insertions and deletions (indels) can be generated with high efficiency, typically exceeding 90% when measured using TIDE analysis

    • Targeting can be designed to disrupt specific functional domains or create complete gene knockouts

  • Experimental design considerations:

    • Guide RNA design should target conserved exons present in all FAM136A transcript isoforms

    • Microinjection into synchronous embryos at early developmental stages ensures widespread genomic editing

    • F0 animals will exhibit mosaicism due to rapid cell divisions and low incubation temperature

    • For germline transmission studies, crossing F0 mosaic animals is necessary to establish stable lines

  • Analysis approaches:

    • Phenotypic evaluation should focus on mitochondrial function in relevant tissues

    • Inner ear development and function may be particularly relevant based on expression patterns

    • Molecular analysis should include verification of editing efficiency and characterization of transcript/protein alterations

While F0 CRISPR-edited Xenopus tropicalis will display mosaicism, the high penetrance of mutations often allows meaningful phenotypic analysis without establishing stable lines, particularly for initial functional screens .

What protein interactions have been identified for FAM136A in Xenopus systems?

Systematic protein interaction studies for FAM136A in Xenopus systems remain limited. Based on available data and localization studies, several potential interaction networks merit investigation:

  • Mitochondrial protein interactions:

    • Co-localization with COX IV in sensory epithelium suggests potential interactions with respiratory chain components

    • Mitochondrial import machinery components likely interact transiently during protein targeting

    • Other mitochondrial matrix proteins may form functional complexes with FAM136A

  • Methodological approaches for interaction studies:

    • Proximity labeling techniques (BioID, APEX) using FAM136A as bait in Xenopus cell systems

    • Co-immunoprecipitation using tagged recombinant FAM136A protein

    • Yeast two-hybrid screening against Xenopus tropicalis cDNA libraries

    • Mass spectrometry analysis of purified mitochondrial complexes containing FAM136A

  • Isoform-specific interactions:

    • Different transcript isoforms of FAM136A may participate in distinct interaction networks

    • Comparative analysis of interaction profiles between isoforms may reveal functional specialization

Researchers should design interaction studies accounting for mitochondrial localization, potentially using mitochondria-targeted split-reporter systems or organelle-specific protein complementation assays to minimize false positives from non-physiological compartment mixing.

What controls should be included when studying FAM136A function in Xenopus tropicalis?

Robust experimental design for FAM136A functional studies requires comprehensive controls addressing both technical and biological variables:

  • Genetic manipulation controls:

    • For CRISPR/Cas9 experiments, include non-targeting gRNA controls to assess injection effects

    • For morpholino studies, include standard control morpholinos and rescue experiments with wildtype FAM136A mRNA to verify specificity

    • For overexpression studies, include equivalent expression of unrelated proteins to control for general protein burden effects

  • Expression analysis controls:

    • For qPCR studies of FAM136A transcript levels, multiple reference genes validated for stability in the experimental context should be used

    • Western blot loading controls should include both housekeeping proteins and markers specific to mitochondrial content

    • Multiple antibodies targeting different epitopes should be used when possible to confirm specificity

  • Functional assay controls:

    • Include positive controls for mitochondrial function assays using established mitochondrial proteins

    • Perform parallel analyses in both Xenopus laevis and Xenopus tropicalis when possible to confirm conserved functions

    • Include genetic background controls, particularly when using inbred or transgenic Xenopus tropicalis strains

Control TypePurposeImplementation
Negative controlsEstablish baseline and non-specific effectsNon-targeting gRNAs, control morpholinos, vehicle treatments
Positive controlsVerify assay functionalityKnown mitochondrial protein manipulations, established phenotypes
Rescue controlsConfirm specificity of observed effectsWild-type FAM136A expression in knockout/knockdown systems
Specificity controlsDistinguish isoform-specific functionsSelective targeting or rescue with specific FAM136A isoforms

How can I design experiments to investigate the mitochondrial function of FAM136A in Xenopus tropicalis?

Investigating the mitochondrial function of FAM136A in Xenopus tropicalis requires a multi-faceted experimental approach:

  • Subcellular localization studies:

    • Generate fluorescently-tagged FAM136A constructs for live imaging in Xenopus cells or embryos

    • Perform co-localization studies with established mitochondrial markers like COX IV

    • Use subcellular fractionation to biochemically confirm mitochondrial association

    • Identify mitochondrial targeting sequences and generate deletion constructs to verify import mechanisms

  • Functional impact assessment:

    • Measure mitochondrial respiration in FAM136A-depleted vs. control cells using respirometry

    • Assess mitochondrial membrane potential with fluorescent indicators following FAM136A manipulation

    • Examine mitochondrial morphology through electron microscopy and fluorescence imaging

    • Analyze mitochondrial protein import efficiency in FAM136A-deficient systems

  • Tissue-specific considerations:

    • Focus analyses on tissues with high FAM136A expression, particularly sensory epithelium

    • Design developmental time-course studies to identify critical periods of FAM136A function

    • Consider examining both larval (pre-metamorphic) and post-metamorphic stages given the fundamental immune and physiological changes that occur during metamorphosis

  • Methodological recommendations:

    • Use conditional knockout or inducible knockdown systems to bypass potential early developmental requirements

    • Incorporate metabolomic analysis to identify biochemical pathways affected by FAM136A deficiency

    • Employ live imaging of developing Xenopus embryos to capture dynamic aspects of mitochondrial behavior

How can I address low expression levels of recombinant Xenopus tropicalis FAM136A?

Low expression of recombinant Xenopus tropicalis FAM136A can be addressed through several optimization strategies:

  • Expression system optimization:

    • Compare yeast, mammalian, and E. coli expression systems to identify optimal host

    • For yeast systems, test different promoter strengths and induction conditions

    • Consider codon optimization of the FAM136A sequence for the expression host

    • Test expression of different FAM136A isoforms, as some may express more efficiently than others

  • Fusion tag strategies:

    • Compare N-terminal vs. C-terminal His tags for impact on expression and folding

    • Test solubility-enhancing fusion partners (SUMO, MBP, GST) while ensuring tag removal does not compromise function

    • Evaluate the impact of tag position on mitochondrial targeting sequences, which may affect folding

  • Culture condition optimization:

    • Adjust temperature, media composition, and induction timing to maximize expression

    • Implement fed-batch culture strategies to achieve higher cell densities and protein yields

    • For difficult constructs, consider low-temperature expression to improve folding kinetics

  • RNA and protein stability enhancements:

    • Identify and modify RNA secondary structures that may impede translation

    • Incorporate stabilizing mutations identified through directed evolution or computational design

    • Implement protease inhibition strategies during expression and purification

When multiple approaches fail to yield sufficient protein, consider whether the native FAM136A contains features inherently challenging for recombinant expression, such as regions prone to aggregation or post-translational modifications critical for stability.

What strategies can help resolve inconsistent results in FAM136A functional studies?

Addressing inconsistency in FAM136A functional studies requires systematic evaluation of experimental variables:

  • Biological source variability:

    • Different strains of Xenopus tropicalis show genetic diversity that may influence experimental outcomes

    • The genetic distance between Nigerian and Ivory Coast strains should be considered when comparing results across studies

    • Developmental stage significantly impacts gene expression and response patterns, particularly during metamorphosis

  • Technical approach standardization:

    • Standardize gene editing protocols, including guide RNA design and delivery methods

    • Implement quantitative assessment of editing efficiency in each experiment

    • Ensure consistent animal husbandry conditions, as temperature and other environmental factors influence Xenopus physiology

  • Isoform-specific considerations:

    • FAM136A exists in multiple transcript isoforms with potentially distinct functions

    • Design experiments to distinguish between isoform-specific effects

    • Ensure knockdown, knockout, or overexpression approaches account for all relevant isoforms

  • Data integration approaches:

    • Implement multiple complementary techniques to assess each aspect of FAM136A function

    • Develop clear phenotypic scoring systems with blinded assessment to reduce observer bias

    • Use statistical approaches appropriate for the inherent variability in biological systems

Researchers should maintain detailed records of all experimental conditions, including animal source, developmental timing, reagent sources, and environmental parameters to facilitate robust cross-study comparisons and reproducibility.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.